相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Physiological release of endogenous tau is stimulated by neuronal activity
Amy M. Pooler et al.
EMBO REPORTS (2013)
Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia
Peder Buchhave et al.
ARCHIVES OF GENERAL PSYCHIATRY (2012)
Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles
Diana Simon et al.
FEBS LETTERS (2012)
Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
Sudad Saman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2012)
Measurement of Aß1-42 in cerebrospinal fluid is influenced by matrix effects
J. Randall Slemmon et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Development and assessment of sensitive immuno-PCR assays for the quantification of cerebrospinal fluid three- and four-repeat tau isoforms in tauopathies
Connie Luk et al.
JOURNAL OF NEUROCHEMISTRY (2012)
Diagnosis of progressive supranuclear palsy: can measurement of tau forms help?
H. Bea Kuiperij et al.
NEUROBIOLOGY OF AGING (2012)
Constitutive secretion of tau protein by an unconventional mechanism
Xiyun Chai et al.
NEUROBIOLOGY OF DISEASE (2012)
Age and diagnostic performance of Alzheimer disease CSF biomarkers
N. Mattsson et al.
NEUROLOGY (2012)
Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease
Randall J. Bateman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Hyperphosphorylation and Cleavage at D421 Enhance Tau Secretion
Vanessa Plouffe et al.
PLOS ONE (2012)
Cleavage of Tau by calpain in Alzheimer's disease: the quest for the toxic 17 kD fragment
Sarika Garg et al.
NEUROBIOLOGY OF AGING (2011)
Tau cleavage and tau aggregation in neurodegenerative disease
Diane P. Hanger et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Proteolytic processing of tau
Yipeng Wang et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2010)
Secretion of human tau fragments resembling CSF-tau in Alzheimer's disease is modulated by the presence of the exon 2 insert
WonHee Kim et al.
FEBS LETTERS (2010)
Analysis of Human Tau in Cerebrospinal Fluid
Katja Hanisch et al.
JOURNAL OF PROTEOME RESEARCH (2010)
Immuno-PCR-based quantification of multiple phosphorylated tau-epitopes linked to Alzheimer's disease
David Singer et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
CSF Biomarkers and Incipient Alzheimer Disease in Patients With Mild Cognitive Impairment
Niklas Mattsson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Enrichment and analysis of Alzheimer's Aβ1-42 peptide in human plasma and whole blood
Noah T. Ditto et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study
Pieter Jelle Visser et al.
LANCET NEUROLOGY (2009)
Pattern of Tau forms in CSF is altered in progressive supranuclear palsy
B. Borroni et al.
NEUROBIOLOGY OF AGING (2009)
The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease
Justyna Maria Czarna Bahl et al.
NEUROBIOLOGY OF AGING (2009)
PET imaging of amyloid deposition in patients with mild cognitive impairment
Anton Forsberg et al.
NEUROBIOLOGY OF AGING (2008)
Tau forms in CSF as a reliable biomarker for progressive supranuclear palsy
B. Borroni et al.
NEUROLOGY (2008)
Epitope mapping of mAbs AT8 and Tau5 directed against hyperphosphorylated regions of the human tau protein
Robert Porzig et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study
O Hansson et al.
LANCET NEUROLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
Measurement of phosphorylated tau epitopes in the differential diagnosis of Alzheimer disease - A comparative cerebrospinal fluid study
H Hampel et al.
ARCHIVES OF GENERAL PSYCHIATRY (2004)
Amyloid beta 1-42, and tau in cerebrospinal fluid after severe traumatic brain injury
G Franz et al.
NEUROLOGY (2003)
CSF Aβ 42 levels correlate with amyloid-neuropathology in a population-based autopsy study
D Strozyk et al.
NEUROLOGY (2003)
Tau conformational changes correspond to impairments of episodic memory in mild cognitive impairment and Alzheimer's disease
N Ghoshal et al.
EXPERIMENTAL NEUROLOGY (2002)
Differential diagnosis of Alzheimer disease with cerebrospinal fluid levels of tau protein phosphorylated at threonine 231
K Buerger et al.
ARCHIVES OF NEUROLOGY (2002)
Levels of nonphosphorylated and phosphorylated tau in cerebrospinal fluid of Alzheimer's disease patients - An ultrasensitive bienzyme-substrate-recycle enzyme-linked Immunosorbent assay
YY Hu et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Large-scale, multicenter study of cerebrospinal fluid tau protein phosphorylated at serine 199 for the antemortem diagnosis of Alzheimer's disease
N Itoh et al.
ANNALS OF NEUROLOGY (2001)
Both total and phosphorylated tau are increased in Alzheimer's disease
M Sjögren et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2001)
Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients
R Kohnken et al.
NEUROSCIENCE LETTERS (2000)
Quantification of tau phosphorylated at threonine 181 in human cerebrospinal fluid:: a sandwich ELISA with a synthetic phosphopeptide for standardization
E Vanmechelen et al.
NEUROSCIENCE LETTERS (2000)
分享论文
